Micromedic – a Cancer Diagnostics Cluster     News
  Micromedic Technologies Ltd. specializes in the development and commercialization of novel and innovative cancer diagnostic products. Our portfolio spans a wide range of cancer and cancer-related indications including colorectal cancer, breast cancer, cervical cancer, bladder cancer, lung cancer, and diagnostic tools for personalized treatment.

Micromedic is a public company traded on the Tel Aviv Stock Exchange (TASE: MCTC).

 
  3-2-2014
Micromedic reports success in clinical pilot of its Cervical Cancer diagnostic product in a centeral hospital in Beijing

8-7-2013
Zetiq has signed a memorandum of understanding for collaboration in India

25-12-2012
Successful interim results in a trial of a test for recurrence of bladder cancer cells in urine specimens

3-10-2012
Zetiq received patent approval in Japan for its cell staining technology

20-11-2012
Marketing approval for Zetiq's CellDetect in China

15-4-2012
BioLight will invest 4 million NIS for additional 5% of Micromedic

27-3-2012
Micromedic signed an investment agreement with BioMarCare Technologies Inc.

25-9-2011
BioLight acquires 21% of Micromedic

© Micromedic Technologies Ltd. site mapcontact  
 
Site by Site2goal | Design Studio Michal Lehavi